Abstract: This invention relates to a stable, sterilized, purified composition having a polymer matrix and a therapeutically effective amount of a drug, wherein the drug can be used to prevent or treat drug-induced, alcohol-induced, biologically-induced, trauma-induced or pain-induced nausea, vomiting, dizziness and other adverse effects arising from but not limited to motion sickness, cancer therapy, and pregnancy. In particular, the polymer matrix may be conformable to topical application on animal skin.
Abstract: Topical gelled compositions comprising a drug which causes vasodilation, and optionally prostaglandin E1, dispersed within a polymer matrix, and, methods of treating sexual dysfunction, including both male and female sexual dysfunction, using said compositions.
Type:
Application
Filed:
February 4, 2003
Publication date:
July 24, 2003
Applicant:
L.A.M. PHARMACEUTICAL CORPORATION
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath
Abstract: Topical gelled compositions comprising a drug which causes vasodilation, and optionally prostaglandin E1, dispersed within a polymer matrix, and methods of treating sexual dysfunction, including both male and female sexual dysfunction, using said compositions.
Type:
Grant
Filed:
May 15, 2001
Date of Patent:
February 4, 2003
Assignee:
L.A.M. Pharmaceutical Corporation
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath
Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
Type:
Grant
Filed:
March 30, 1999
Date of Patent:
May 14, 2002
Assignee:
L.A.M. Pharmaceutical Corporation
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath
Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
Type:
Grant
Filed:
April 8, 1999
Date of Patent:
February 12, 2002
Assignee:
L. A. M. Pharmaceutical Corporation
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath
Abstract: Sustained release compositions comprising a drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
Type:
Grant
Filed:
February 28, 2000
Date of Patent:
January 1, 2002
Assignee:
L.A.M. Pharmaceutical Corporation
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath
Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
Type:
Grant
Filed:
March 29, 2000
Date of Patent:
January 1, 2002
Assignee:
L.A.M. Pharmaceutical Corporation
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath
Abstract: Topical gelled compositions comprising a drug which causes vasodilation, and optionally prostaglandin E1, dispersed within a polymer matrix, and methods of treating sexual dysfunction, including both male and female sexual dysfunction, using said compositions.
Type:
Grant
Filed:
September 8, 1998
Date of Patent:
June 26, 2001
Assignee:
L.A.M. Pharmaceutical Corporation
Inventors:
Alan Drizen, Peter Rothbart, Gary M. Nath